Therapeuticsmd Inc (TXMD)

Jul 16, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Jul 16, 2026

Jul 15, 2026

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jul 15, 2026

Jul 13, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jul 13, 2026

Jul 10, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Amid Ongoing ChallengesEarnings Call Highlights - DonanımHaber

Jul 10, 2026

Jul 07, 2026

TherapeuticsMD (TXMD) News Flow - Moomoo

Jul 07, 2026

Jul 02, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jul 02, 2026

Jun 30, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 30, 2026

Jun 27, 2026

TherapeuticsMD (TXMD) Rallies 3.94% as Stock Approaches Key Resistance at $2.22Stop Run - dars.gov.et

Jun 27, 2026

Jun 26, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of TherapeuticsMD, Inc. – NASDAQ:TXMD - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to revenue forward of TherapeuticsMD, Inc. – NASDAQ:TXMD - TradingView

Jun 26, 2026

Jun 24, 2026

TherapeuticsMD Inc (TXMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 24, 2026

Jun 23, 2026

TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 23, 2026

Jun 23, 2026

TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026

Jun 22, 2026

TherapeuticsMD Inc (TXMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 22, 2026

Jun 22, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Jun 22, 2026

Jun 22, 2026

TherapeuticsMD Inc (TXMD) Institutional Confidence - TradingKey

Jun 22, 2026

Jun 18, 2026

TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026

Jun 17, 2026

TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

TherapeuticsMD Inc (TXMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates Amid Continued Cash BurnNet Income Trends - newsline.com

Jun 17, 2026

Jun 15, 2026

TherapeuticsMD (TXMD) Gains 3.64%, Tests Resistance at $2.39High Low Breadth - newsline.com

Jun 15, 2026

Jun 14, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates Sharply, Yet Stock Surges 20.9%EPS Surprise History - newsline.com

Jun 14, 2026

Jun 11, 2026

TXMD Q3 2023 Earnings: Wider-than-Expected Loss Highlights Operational ChallengesProfit Inflection Point - newsline.com

Jun 11, 2026

Jun 10, 2026

TherapeuticsMD (TXMD) Nears Support Amid Modest Selling PressureIndex Put Call - newsline.com

Jun 10, 2026

Jun 10, 2026

TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance ZoneAAII Neutral - newsline.com

Jun 10, 2026

Jun 04, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jun 04, 2026

Jun 02, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Highlights Ongoing ChallengesEarnings Quality Score - dars.gov.et

Jun 02, 2026

May 30, 2026

TXMDTherapeuticsMD Inc Stock Price and Quote - Finviz

May 30, 2026

May 29, 2026

TXMD Q3 2023 Earnings: Deep EPS Miss Overshadowed by Strategic ProgressNegative Surprise Momentum - newsline.com

May 29, 2026

May 29, 2026

TXMD Q3 2023 Earnings: Significant EPS Miss Amid Operational ChallengesTrough Earnings Signal - The Legal Advocate

May 29, 2026

May 28, 2026

TXMD Q3 2023 Earnings: Wider-Than-Expected Loss Amid Zero RevenuePositive Surprise Momentum - DonanımHaber

May 28, 2026

May 27, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates, Stock DeclinesPost-Earnings Drift - newsline.com

May 27, 2026

May 27, 2026

TXMD Q3 2023 Earnings: EPS Misses Estimates by Wide Margin Amidst Operational ChallengesSaaS Earnings Trends - dars.gov.et

May 27, 2026

May 24, 2026

TXMD Q3 2023 Earnings: A Significant EPS Miss Amid No Reported RevenueLow Growth Earnings - newsline.com

May 24, 2026

May 22, 2026

TherapeuticsMD (TXMD) Edges Higher as Support Holds Near $2.01Post-Earnings Moves - Newser

May 22, 2026

May 17, 2026

What TherapeuticsMD TXMD flagged as biggest challenges ahead Q3 2023 EPS Misses ViewsBanking Earnings Report - The Legal Advocate

May 17, 2026

May 13, 2026

TherapeuticsMD Announces First Quarter 2026 Financial Results - BioSpace

May 13, 2026